[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

PostMenopausal Osteoporosis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... with each drug. Companies participating in PostMenopausal Osteoporosis pipeline Profiled in detail ... PostMenopausal Osteoporosis treatment pipeline. The report includes: The research work provides comprehensive overview of PostMenopausal Osteoporosis pipeline and treatment landscape Complete list of drug ...

April 2019 70 pages

Premature Ejaculation - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in Premature Ejaculation pipeline Profiled in detail Key ... Premature Ejaculation treatment pipeline. The report includes: The research work provides comprehensive overview of Premature Ejaculation pipeline and treatment landscape Complete list of drug ...

April 2019 40 pages

Premature Labor - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments, pharmacological action and recent developments associated with each drug. Companies participating in Premature Labor pipeline Profiled in detail Key players actively participating in constipation ...

April 2019 42 pages

Premenstrual Syndrome - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in Premenstrual Syndrome pipeline Profiled in detail Key ... Premenstrual Syndrome treatment pipeline. The report includes: The research work provides comprehensive overview of Premenstrual Syndrome pipeline and treatment landscape Complete list of drug ...

April 2019 35 pages

Primary Biliary Cirrhosis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... Report assists users in taking actionable steps Primary Biliary Cirrhosis pipeline report enables users to gain clear understanding ... business in Primary Biliary Cirrhosis treatment pipeline. The report includes: The research work provides comprehensive overview of Primary Biliary Cirrhosis pipeline and ...

April 2019 88 pages

Primary Hyperoxaluria - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in Primary Hyperoxaluria pipeline Profiled in detail Key ... Primary Hyperoxaluria treatment pipeline. The report includes: The research work provides comprehensive overview of Primary Hyperoxaluria pipeline and treatment landscape Complete list of drug ...

April 2019 46 pages

Primary Sclerosing Cholangitis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... Report assists users in taking actionable steps Primary Sclerosing Cholangitis pipeline report enables users to gain clear understanding ... in Primary Sclerosing Cholangitis treatment pipeline. The report includes: The research work provides comprehensive overview of Primary Sclerosing Cholangitis pipeline and ...

April 2019 82 pages

Proliferative Diabetic Retinopathy (PDR) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... with each drug. Companies participating in Proliferative Diabetic Retinopathy (PDR) pipeline Profiled in detail Key players ... Proliferative Diabetic Retinopathy (PDR) treatment pipeline. The report includes: The research work provides comprehensive overview of Proliferative Diabetic Retinopathy (PDR) ...

April 2019 45 pages

Ragweed Pollen Allergy - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Report assists users in taking actionable steps Ragweed Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Ragweed Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Ragweed Pollen Allergy pipeline and treatment ...

April 2019 39 pages

Reflux Esophagitis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments associated with each drug. Companies participating in Reflux Esophagitis pipeline Profiled in detail Key ... Reflux Esophagitis treatment pipeline. The report includes: The research work provides comprehensive overview of Reflux Esophagitis pipeline and treatment landscape Complete list of drug ...

April 2019 76 pages

Secondary Hyperparathyroidism (SHPT) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... assists users in taking actionable steps Secondary Hyperparathyroidism (SHPT) pipeline report enables users to gain clear ... in Secondary Hyperparathyroidism (SHPT) treatment pipeline. The report includes: The research work provides comprehensive overview of Secondary Hyperparathyroidism (SHPT) pipeline and ...

April 2019 52 pages

Secondary Hypogonadism (Hypogonadotropic Hypogonadism) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Companies participating in Secondary Hypogonadism (Hypogonadotropic Hypogonadism) pipeline Profiled in ... Secondary Hypogonadism (Hypogonadotropic Hypogonadism) treatment pipeline. The report includes: The research work provides comprehensive overview of Secondary Hypogonadism (Hypogonadotropic Hypogonadism ...

April 2019 53 pages

Short Bowel Syndrome - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... . Report assists users in taking actionable steps Short Bowel Syndrome pipeline report enables users to gain clear understanding into ... business in Short Bowel Syndrome treatment pipeline. The report includes: The research work provides comprehensive overview of Short Bowel Syndrome pipeline and treatment ...

April 2019 65 pages

Sicca Syndrome - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments, pharmacological action and recent developments associated with each drug. Companies participating in Sicca Syndrome pipeline Profiled in detail Key players actively participating in constipation ...

April 2019 95 pages

sjogren syndrome - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments, pharmacological action and recent developments associated with each drug. Companies participating in sjogren syndrome pipeline Profiled in detail Key players actively participating in constipation ...

April 2019 92 pages

Systemic Mastocytosis - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in Systemic Mastocytosis pipeline Profiled in detail Key ... Systemic Mastocytosis treatment pipeline. The report includes: The research work provides comprehensive overview of Systemic Mastocytosis pipeline and treatment landscape Complete list of drug ...

April 2019 60 pages

Urinary Incontinence - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... developments associated with each drug. Companies participating in Urinary Incontinence pipeline Profiled in detail Key ... Urinary Incontinence treatment pipeline. The report includes: The research work provides comprehensive overview of Urinary Incontinence pipeline and treatment landscape Complete list of drug ...

April 2019 70 pages

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... associated with each drug. Companies participating in Vaginal Atrophy (Atrophic Vaginitis) pipeline Profiled in detail Key players actively ... in Vaginal Atrophy (Atrophic Vaginitis) treatment pipeline. The report includes: The research work provides comprehensive overview of Vaginal Atrophy (Atrophic Vaginitis) ...

April 2019 35 pages

Vasomotor Symptoms (Menopausal Hot Flashes) - Pipeline Drugs and Companies, Q2 2019

US$ 1,799.00

... with each drug. Companies participating in Vasomotor Symptoms (Menopausal Hot Flashes) pipeline Profiled in detail Key players ... Vasomotor Symptoms (Menopausal Hot Flashes) treatment pipeline. The report includes: The research work provides comprehensive overview of Vasomotor Symptoms (Menopausal Hot Flashes) ...

April 2019 59 pages

2019 Acinetobacter baumannii (Acinetobacter Infections) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Acinetobacter baumannii (Acinetobacter Infections) pipeline companies from advancing their products. Acinetobacter baumannii (Acinetobacter Infections) Report Description The H1-2019 pipeline review report on Acinetobacter baumannii (Acinetobacter Infections) is a comprehensive study ...

March 2019 150 pages

2019 African Trypanosomiasis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the African Trypanosomiasis pipeline companies from advancing their products. African Trypanosomiasis Report Description The H1-2019 pipeline review report on African Trypanosomiasis is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Anemia in Chronic Kidney Disease (Renal Anemia) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... Anemia in Chronic Kidney Disease (Renal Anemia) pipeline companies from advancing their products. Anemia in Chronic Kidney Disease (Renal Anemia) Report Description The H1-2019 pipeline review report on Anemia in Chronic Kidney Disease (Renal Anemia ...

March 2019 86 pages

2019 Anthrax R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Anthrax pipeline companies from advancing their products. Anthrax Report Description The H1-2019 pipeline review report on Anthrax is a comprehensive study on drug candidates across different ...

March 2019 71 pages

2019 Aplastic Anemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Aplastic Anemia pipeline companies from advancing their products. Aplastic Anemia Report Description The H1-2019 pipeline review report on Aplastic Anemia is a comprehensive study on drug candidates ...

March 2019 59 pages

2019 Aspergillosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Aspergillosis pipeline companies from advancing their products. Aspergillosis Report Description The H1-2019 pipeline review report on Aspergillosis is a comprehensive study on drug candidates across different ...

March 2019 75 pages

2019 Bacillary Dysentery (Shigellosis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... Bacillary Dysentery (Shigellosis) pipeline companies from advancing their products. Bacillary Dysentery (Shigellosis) Report Description The H1-2019 pipeline review report on Bacillary Dysentery (Shigellosis ... and universities participating in the Bacillary Dysentery (Shigellosis) product pipeline are provided. ...

March 2019 40 pages

2019 Bacterial Vaginosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Bacterial Vaginosis pipeline companies from advancing their products. Bacterial Vaginosis Report Description The H1-2019 pipeline review report on Bacterial Vaginosis is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Botulism R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Botulism pipeline companies from advancing their products. Botulism Report Description The H1-2019 pipeline review report on Botulism is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Burkholderia pseudomallei Infections (Melioidosis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Burkholderia pseudomallei Infections (Melioidosis) pipeline companies from advancing their products. Burkholderia pseudomallei Infections (Melioidosis) Report Description The H1-2019 pipeline review report on Burkholderia pseudomallei Infections (Melioidosis) is a comprehensive study ...

March 2019 50 pages

2019 Candidiasis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Candidiasis pipeline companies from advancing their products. Candidiasis Report Description The H1-2019 pipeline review report on Candidiasis is a comprehensive study on drug candidates across different ...

March 2019 130 pages

2019 Chagas Disease (American Trypanosomiasis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Chagas Disease (American Trypanosomiasis) pipeline companies from advancing their products. Chagas Disease (American Trypanosomiasis) Report Description The H1-2019 pipeline review report on Chagas Disease (American Trypanosomiasis) is a comprehensive study on drug ...

March 2019 65 pages

2019 Chikungunya Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Chikungunya Fever pipeline companies from advancing their products. Chikungunya Fever Report Description The H1-2019 pipeline review report on Chikungunya Fever is a comprehensive study on drug candidates ...

March 2019 80 pages

2019 Chlamydia Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Chlamydia Infections pipeline companies from advancing their products. Chlamydia Infections Report Description The H1-2019 pipeline review report on Chlamydia Infections is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Cholera R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Cholera pipeline companies from advancing their products. Cholera Report Description The H1-2019 pipeline review report on Cholera is a comprehensive study on drug candidates across different ...

March 2019 45 pages

2019 Coccidioidomycosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Coccidioidomycosis pipeline companies from advancing their products. Coccidioidomycosis Report Description The H1-2019 pipeline review report on Coccidioidomycosis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Community Acquired Pneumonia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... Community Acquired Pneumonia pipeline companies from advancing their products. Community Acquired Pneumonia Report Description The H1-2019 pipeline review report on Community Acquired Pneumonia ... providers and universities participating in the Community Acquired Pneumonia product pipeline are provided. Company ...

March 2019 70 pages

2019 Cryptococcosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Cryptococcosis pipeline companies from advancing their products. Cryptococcosis Report Description The H1-2019 pipeline review report on Cryptococcosis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Cryptosporidiosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Cryptosporidiosis pipeline companies from advancing their products. Cryptosporidiosis Report Description The H1-2019 pipeline review report on Cryptosporidiosis is a comprehensive study on drug candidates across different ...

March 2019 35 pages

2019 Diphtheria R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Diphtheria pipeline companies from advancing their products. Diphtheria Report Description The H1-2019 pipeline review report on Diphtheria is a comprehensive study on drug candidates across different ...

March 2019 66 pages

2019 Elephantiasis (Lymphatic Filariasis) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... Elephantiasis (Lymphatic Filariasis) pipeline companies from advancing their products. Elephantiasis (Lymphatic Filariasis) Report Description The H1-2019 pipeline review report on Elephantiasis (Lymphatic Filariasis ... universities participating in the Elephantiasis (Lymphatic Filariasis) product pipeline are ...

March 2019 30 pages

2019 Epstein–Barr Virus (EBV) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Epstein–Barr Virus (EBV) Infections pipeline companies from advancing their products. Epstein–Barr Virus (EBV) Infections Report Description The H1-2019 pipeline review report on Epstein–Barr Virus (EBV) Infections is a comprehensive study on drug ...

March 2019 90 pages

2019 Fanconi Anemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Fanconi Anemia pipeline companies from advancing their products. Fanconi Anemia Report Description The H1-2019 pipeline review report on Fanconi Anemia is a comprehensive study on drug candidates ...

March 2019 52 pages

2019 Genital Herpes R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Genital Herpes pipeline companies from advancing their products. Genital Herpes Report Description The H1-2019 pipeline review report on Genital Herpes is a comprehensive study on drug candidates ...

March 2019 67 pages

2019 Gonorrhea R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... holding some of the Gonorrhea pipeline companies from advancing their products. Gonorrhea Report Description The H1-2019 pipeline review report on Gonorrhea is a comprehensive study on drug candidates across different ...

March 2019 50 pages

2019 Haemophilus influenzae Type B Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... Haemophilus influenzae Type B Infections pipeline companies from advancing their products. Haemophilus influenzae Type B Infections Report Description The H1-2019 pipeline review report on Haemophilus influenzae Type ... universities participating in the Haemophilus influenzae Type B Infections product pipeline ...

March 2019 60 pages

2019 Hand-Foot-Mouth Disease R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Hand-Foot-Mouth Disease pipeline companies from advancing their products. Hand-Foot-Mouth Disease Report Description The H1-2019 pipeline review report on Hand-Foot-Mouth Disease is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Hemophilia A R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Hemophilia A pipeline companies from advancing their products. Hemophilia A Report Description The H1-2019 pipeline review report on Hemophilia A is a comprehensive study on drug candidates ...

March 2019 120 pages

2019 Hemophilia B R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Hemophilia B pipeline companies from advancing their products. Hemophilia B Report Description The H1-2019 pipeline review report on Hemophilia B is a comprehensive study on drug candidates ...

March 2019 92 pages

2019 Hepatitis A R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Hepatitis A pipeline companies from advancing their products. Hepatitis A Report Description The H1-2019 pipeline review report on Hepatitis A is a comprehensive study on drug candidates ...

March 2019 30 pages

2019 Hepatitis D(HDV) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 2,199.00

... are holding some of the Hepatitis D(HDV) pipeline companies from advancing their products. Hepatitis D(HDV) Report Description The H1-2019 pipeline review report on Hepatitis D(HDV) is a comprehensive study on drug candidates ...

March 2019 50 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers